The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Metastatic site pattern as predictor of outcome of first-line alternating oxaliplatin-based chemotherapy and nivolumab for patients with microsatellite-stable (MSS) colorectal cancer (CRC).
 
Anne Ree
Honoraria - Bristol-Myers Squibb Norway; Takeda
Consulting or Advisory Role - Takeda
Research Funding - Bristol-Myers Squibb Norway (Inst)
 
Anne Negård
Honoraria - Bristol-Myers Squibb Norway
 
Stein Harald Holmedal
No Relationships to Disclose
 
Paula Bousquet
No Relationships to Disclose
 
Sebastian Meltzer
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - AstraZeneca (Inst); BMS Norway (Inst); Illumina (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Roche (Inst)